Vivo Capital’s Precision BioSciences DTIL Stock Holding History

Vivo Capital’s Portfolio DTIL Stock Details DTIL Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$36.7K	Hold	4,675	–	–	﹤0.01%	47
2026 Q1	$25.7K	Hold	4,675	–	–	﹤0.01%	46
2025 Q4	$19.4K	Hold	4,675	–	–	﹤0.01%	47
2025 Q3	$25.8K	Hold	4,675	–	–	﹤0.01%	47
2025 Q2	$19.6K	Hold	4,675	–	–	﹤0.01%	42
2025 Q1	$22.3K	Hold	4,675	–	–	﹤0.01%	40
2024 Q4	$17.8K	Hold	4,675	–	–	﹤0.01%	40
2024 Q3	$41.9K	Hold	4,675	–	–	﹤0.01%	43
2024 Q2	$45.5K	Hold	4,675	–	–	﹤0.01%	42
2024 Q1	$63.4K	Hold	4,675	–	–	0.01%	42
2023 Q4	$51.2K	Hold	4,675	–	–	﹤0.01%	47
2023 Q3	$47.9K	Hold	4,675	–	–	0.01%	53
2023 Q2	$73.8K	Hold	4,675	–	–	0.01%	48
2023 Q1	$106K	Hold	4,675	–	–	0.01%	48
2022 Q4	$167K	Hold	4,675	–	–	0.02%	48
2022 Q3	$182K	Hold	4,675	–	–	0.02%	50
2022 Q2	$224K	Hold	4,675	–	–	0.02%	48
2022 Q1	$432K	Hold	4,675	–	–	0.03%	52
2021 Q4	$1.04M	Hold	4,675	–	–	0.06%	53
2021 Q3	$1.62M	Hold	4,675	–	–	0.07%	57
2021 Q2	$1.76M	Hold	4,675	–	–	0.08%	57
2021 Q1	$1.45M	Hold	4,675	–	–	0.05%	61
2020 Q4	$1.17M	Hold	4,675	–	–	0.05%	57
2020 Q3	$864K	Hold	4,675	–	–	0.05%	64
2020 Q2	$1.17M	Hold	4,675	–	–	0.08%	54
2020 Q1	$846K	Buy	+4,675	New	+$1.22M	0.08%	53
2019 Q3	–	Sell	-9,350	Closed	-$3.72M	–	15
2019 Q2	$3.72M	Hold	9,350	–	–	0.35%	37
2019 Q1	$5.04M	Buy	+9,350	New	+$4.96M	0.5%	37

Other funds holding DTIL

Aberdeen Group Edinburgh, United Kingdom $71.2B AUM 41.74% 1-Year Est. Return

Bleichroeder LP New York $559M AUM 83.7% 1-Year Est. Return

OCA

Octagon Capital Advisors New York $1.11B AUM 866.76% 1-Year Est. Return

BFM

Boothbay Fund Management New York $7.6B AUM 109.3% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

LCM

Lynx1 Capital Management San Juan, Puerto Rico $866M AUM 231.68% 1-Year Est. Return

DCM

Driehaus Capital Management Chicago, Illinois $17.3B AUM 211.34% 1-Year Est. Return

EAM

Empery Asset Management New York $86.5M AUM

AAA

Affinity Asset Advisors New York $2.21B AUM 431.26% 1-Year Est. Return

Vivo Capital's DTIL Position: Q2 2026 in Review

Vivo Capital held its Precision BioSciences (DTIL) position steady in Q2 2026 at 4,675 shares worth $36.7K. The position accounts for ﹤0.01% of the portfolio, ranked #47.

Vivo Capital first reported a position in DTIL in Q1 2019 and has held it in 28 quarters since. The position peaked at $5.04M in Q1 2019. 95 funds tracked by Wall St. Rank hold DTIL as of Q2 2026.

Vivo Capital held 4,675 shares of Precision BioSciences worth $36.7K as of Q2 2026.
Vivo Capital left its Precision BioSciences share count unchanged in Q2 2026.
Precision BioSciences made up ﹤0.01% of Vivo Capital's portfolio in Q2 2026, its #47 holding.
Vivo Capital first reported a position in Precision BioSciences in Q1 2019 and has held it in 28 quarters since.
Vivo Capital's Precision BioSciences position peaked at $5.04M in Q1 2019.
95 funds tracked by Wall St. Rank held Precision BioSciences as of Q2 2026.

Based on Vivo Capital's 13F filing for Q2 2026, filed 14 Aug 2026.